ClinicalTrials.gov
public full text
Public Domain
Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
The purpose of this study is : \- to evaluate the hemodynamic tolerance of esmolol titrated to obtain a lowering of heart rate of 10% or 20%.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Heart Rate Control With Esmolol in Septic Shock#867063
- Comparison of the efficacy and safety of Landiolol and Esmolol in critically ill patients: a propensity score-matched study#392016
- Tranexamic Acid Dose and Remifentanil Titration in Septorhinoplasty#1124992
- EVLWI Exhibits Pulmonary and Systemic Permeability in Sepsis Related ALI/ARDS#906116
- Temperature Gradients for Sepsis Severity and Fluid Resuscitation#855975
Record · ID 1162522
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive